A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among these were many gene products currently known to be associated with hereditary nephrotic syndrome (Sadowski et al., 2015).”
From A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes (2018) · cites this paper as Sadowski et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
The spectrum of podocytopathies: A unifying view of glomerular diseases
Wiggins, R.-C. (2007) · Kidney International · doi:10.1038/sj.ki.5002222 · Cited by 757
Hinkes, B., Wiggins, R. C., Gbadegesin, R., Vlangos, C. N., Seelow, D., Nürnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B. E., et al. (2006) · Nature Genetics · doi:10.1038/ng1918 · Cited by 569
Self-citationSmith, J. M., Stablein, D. M., Munoz, R., Hebert, D., & McDonald, R. A. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00704.x · Cited by 479
Hinkes, B. G., Mucha, B., Vlangos, C. N., Gbadegesin, R., Liu, J., Hasselbacher, K., Hangan, D., Ozaltin, F., Zenker, M., Hildebrandt, F., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-2164 · Cited by 444
Self-citationRuf, R. G., Lichtenberger, A., Karle, S. M., Haas, J. P., Anacleto, F. E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.-M., Mucha, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113552.59155.72 · Cited by 417
Self-citationCOQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., Xie, L. X., Salviati, L., Hurd, T. W., Vega-Warner, V., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45693 · Cited by 398
Self-citationWeber, S., Gribouval, O., Esquivel, E. L., Morinière, V., Tête, M.-J., Legendre, C., Niaudet, P., & Antignac, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00776.x · Cited by 375
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
Ashraf, S., Gee, H. Y., Woerner, S., Xie, L. X., Vega-Warner, V., Lovric, S., Fang, H., Song, X., Cattran, D. C., Avila-Casado, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69000 · Cited by 341
Self-citationGetting a foothold in nephrotic syndrome
Somlo, S., & Mundel, P. (2000) · Nature Genetics · doi:10.1038/74139 · Cited by 271
Cited by
Items 401–500 of 651
Schneider, R., Shril, S., Buerger, F., Deutsch, K., Yousef, K., Frank, C. N., Onuchic-Whitford, A. C., Kitzler, T. M., Mao, Y., Klämbt, V., et al. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101280 · Cited by 4
Self-citationRecessive variants in MYO1C as a potential novel cause of proteinuric kidney disease
Elmubarak, I., Shril, S., Mansour, B., Bao, A., Kolvenbach, C. M., Kari, J. A., Shalaby, M. A., Desoky, S. M. E., Hildebrandt, F., & Schneider, R. (2024) · Pediatric Nephrology · doi:10.1007/s00467-024-06426-1 · Cited by 5
“As we describe in prior studies [8, 10, 26], our cohort consists of individuals between the ages of 0 and 25 years.”
Self-citationPark, P. G., Choi, S., Ahn, Y. H., Kim, S. H., Kim, C., Kim, H. J., & Kang, H. G. (2025) · Pediatric Nephrology · doi:10.1007/s00467-024-06611-2 · Cited by 4
Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains
Papeta, N., Patel, A. M., D’Agati, V. D., & Gharavi, A. G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163860 · Cited by 4
MOLECULAR DESIGN OF THE KIDNEY FILTRATION BARRIER.
Benzing, T. R. (2020) · Transactions of the American Clinical and Climatological Association · Cited by 5
Molecular Study of Childhood Steroid-Resistant Nephrotic Syndrome: A Hospital-Based Study
Singh, A., Singh, A., Mishra, O. P., Prasad, R., Narayan, G., Batra, V. V., Tabatabaeifar, M., & Schaefer, F. S. (2021) · Journal of Pediatric Genetics · doi:10.1055/s-0040-1722286 · Cited by 4
A broad clinical spectrum of PLCε1-related kidney disease and intrafamilial variability
Yılmaz, E. K., Saygılı, S., Gülhan, B., Canpolat, N., Bayazıt, A. K., Kılıç, B. D., Akıncı, N., Benzer, M., Göknar, N., Tufan, A. K., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-021-05371-7 · Cited by 4
“Several subsequent studies have reported that PLCε1 mutations account for 2–4% of children with steroid-resistant nephrotic syndrome (SRNS) and DMS is the most common histopathological finding [6, 7].”
BackgroundMiura, K., Kaneko, N., Hashimoto, T., Ishizuka, K., Shirai, Y., Hisano, M., Chikamoto, H., Akioka, Y., Kanda, S., Harita, Y., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05604-3 · Cited by 4
“However, in patients older than 1 year of age, WT1 and NPHS2 are the most frequently occurring variants, while NPHS1 variants are less common [10].”
BackgroundGenetic Spectrum of Nephrotic Syndrome: Impact of Podocytopathy in Adult Life
Massengill, S. F., & Trachtman, H. (2022) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2022.04.005 · Cited by 4
Liu, P., Gunther, L. K., Garone, M. E., Zhang, C., Perez, D., Bi‐Karchin, J., Pellenz, C. D., Chase, S. E., Presti, M. F., Plante, É., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021111505 · Cited by 5
Self-citationAbdou, M. M., Ramadan, A., El-Agamy, B., El-Farsy, M. S., & Saleh, E. M. R. M. (2022) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-022-00353-2 · Cited by 4
“This defect is a causative agent for kidney disease [8, 9], and is the major cause of isolated DMS [10].”
BackgroundSaberi, F., Dehghan, Z., Noori, E., & Zali, H. (2023) · ̒Ulūm va funūn-i bastah/bandī · doi:10.61186/ibj.3871 · Cited by 4
Steroid-resistentes nephrotisches Syndrom
Hoefele, J., Beck, B. B., Weber, L. T., & Brinkkoetter, P. T. (2018) · Medizinische Genetik · doi:10.1007/s11825-018-0215-1 · Cited by 6
Promises and pitfalls of whole-exome sequencing exemplified by a nephrotic syndrome family
Guaragna, M. S., Lutaif, A. C. G. D. B., de Souza, M. L., Maciel‐Guerra, A. T., Belangero, V. M. S., Guerra‐Júnior, G., & de Mello, M. P. (2019) · Molecular Genetics and Genomics · doi:10.1007/s00438-019-01609-0 · Cited by 4
“2014; Sampson and Pollak 2015; Bullich et al.”
Genetic Basis of Steroid Resistant Nephrotic Syndrome
Park, E. (2019) · Journal of the Korean Society of Pediatric Nephrology · doi:10.3339/jkspn.2019.23.2.86 · Cited by 8
Rovin, B. H., Caster, D. J., Cattran, D. C., Gibson, K. L., Hogan, J. J., Moeller, M. J., Roccatello, D., Cheung, M., Wheeler, D. C., Winkelmayer, W. C., et al. (2021) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2021-25-1-96-119 · Cited by 4
Recurrent FSGS Postkidney Transplant: Moving the Needle Forward
Amaral, S. G., & Neu, A. M. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09520916 · Cited by 4
Meeting report of the 2017 KidGen Renal Genetics Symposium
Collaborative, O. B. O. T. K., Jayasinghe, K., Quinlan, C., Stark, Z., Patel, C., Sampson, M. G., Saleem, M. A., & Mallett, A. J. (2018) · Human Genomics · doi:10.1186/s40246-018-0137-7 · Cited by 4
“Professor Little and her team developed a protocol for the successful differentiation of human pluripotent stem cells to a kidney organoid [14, 15].”
BackgroundJin, Y., Feng, B.-Y., & Mao, J. (2018) · World Journal of Pediatrics · doi:10.1007/s12519-018-0156-4 · Cited by 4
Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Liu, I. D., Willis, N. S., Craig, J. C., & Hodson, E. M. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003594.pub7 · Cited by 3
Structural conformations of intrinsically disordered proteins of podocyte slit-diaphragm
Padmanaban, H. K., Bheemireddy, S., Mulukala, S. K. N., Dunna, N. R., & Pasupulati, A. K. (2025) · Computational and Structural Biotechnology Reports · doi:10.1016/j.csbr.2025.100060 · Cited by 3
Mettl3 ‐Mediated m6A Modification Represents a Novel Therapeutic Target for FSGS
Zhu, F., Li, H., Li, X., Du, C., Wang, T., Zhou, X., Xie, X., Shao, Y., Huang, Y., Hu, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202501242 · Cited by 5
Antal-Kónya, V., Schay, G., Kétszeri, M., Balogh, E., Mikó, Á., Seidl, D., Keszthelyi, T. M., Bernáth, M., Ungvári-Veres, A., Dorval, G., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524893123 · Cited by 3
Tanzi, A., Buono, L., Grange, C., Iampietro, C., Brossa, A., Arcolino, F. O., Arigoni, M., Calogero, R., Perin, L., Deaglio, S., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05575-z · Cited by 3
“…proteins (NPHS1 coding for nephrin, and NPHS2 coding for podocin), and for mesangial matrix synthesis (among which COL4A3, COL4A4 and COL4A5, mutated in Alport syndrome and in a percentage of cases of steroid-resistant nephrotic syndrome, as well as LAMB2 coding for laminin subunit beta) [6, 7].”
BackgroundLi, S., Hu, M., He, C., Sun, Y., Huang, W., Lei, F.-Y., Liu, Y., Huang, Z., Meng, Y., Liu, W., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0304864 · Cited by 3
Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies
Horinouchi, T., Nozu, K., & Iijima, K. (2025) · Clinical and Experimental Nephrology · doi:10.1007/s10157-025-02645-4 · Cited by 5
“Various podocyte-related genes have been subsequently revealed to cause genetic NS. Approximately 30% of patients with steroid-resistant NS have a single causative gene associated with podocytes [15, 19, 20].”
Piekoszewska‐Ziętek, P., Pańczyk-Tomaszewska, M., & Olczak‐Kowalczyk, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082696 · Cited by 3
“However, prolonged steroid use can lead to cumulative adverse effects [6,20].”
Utility of Genetic Information for Management in Kidney Transplantation and Living Donation
Çalışkan, Y., & Thomas, C. P. (2025) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2025.151658 · Cited by 6
New advances in the treatment of glomerular disease
Maas, R. J. H., & Wetzels, J. F. M. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.195 · Cited by 3
The Democratization of Genomic Inquiry Empowers Our Understanding of Nephrotic Syndrome
Sampson, M. G. (2017) · Transplantation · doi:10.1097/tp.0000000000001897 · Cited by 3
Gaber, A., Alharthi, A. A., Hassan, M. M., El‐Hallous, E. I., Abukhatwah, M. W., Almalki, A. M., Muzallef, A. A., Alotaibi, S. S., Aljuaid, B. S., & Alsanie, W. F. (2020) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2020.365.374 · Cited by 3
Francis, A., Prestidge, C., Kausman, J., Page, A. K. L., Larkins, N., & McCarthy, H. J. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05270-x · Cited by 3
Bai, L., Zhuang, J., Zhang, C., Chen, L., Tian, X., & Jiang, H. F. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.692727 · Cited by 3
Shi, J., Li, W., Tao, R., Zhou, D., Guo, Y., Fu, H., Sun, A., Zhang, J., & Mao, J. (2022) · Laboratory Medicine · doi:10.1093/labmed/lmac062 · Cited by 4
A new era for steroid-resistant nephrotic syndrome in childhood
Ingelfinger, J. R. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.005 · Cited by 3
Conference, I. (2022) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2022.155705.6725 · Cited by 3
Clinical Aspects of Genetic Forms of Nephrotic Syndrome
Boyer, O., Gbadegesin, R., & Waters, A. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_91 · Cited by 4
Piteková, B., Bezdíčka, M., Konopásek, P., Breza, J., Jr., Barton, P., & Zieg, J. (2022) · Clinical and Experimental Nephrology · doi:10.1007/s10157-022-02305-x · Cited by 3
“NPHS2 is the most common affected gene in children and adolescents with SRNS [9, 14, 26].”
BackgroundLi, R., Dong, W., Chen, Y., Tang, T., Zhao, X., Zhang, L., & Liang, X. (2023) · Medicine · doi:10.1097/md.0000000000032683 · Cited by 3
“Gene mutation is an important etiology of FSGS.”
BackgroundInfluentialGenomic testing in patients with renal disease
Lyulcheva-Bennett, K., Williams, S., Howse, M., & McCann, E. (2023) · British Journal of Hospital Medicine · doi:10.12968/hmed.2023.0085 · Cited by 3
Advances in Diagnosis and Treatment of Inherited Kidney Diseases in Children
Wang, G., Liao, M., Tan, D. J., Chen, X., Chao, R., Zhu, Y., Pan, L., Guan, Y., Mao, J., & Hu, L. (2024) · Kidney Diseases · doi:10.1159/000541564 · Cited by 5
“CNS is frequently caused by mutations in genes encoding glomerular fi ltration barrier structural proteins or other related genes [12, 13].”
Gut dysbiosis as a susceptibility factor in childhood idiopathic nephrotic syndrome
Kaneko, K. (2024) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2024.10.003 · Cited by 4
Stahl, R. A. K., & Hoxha, E. (2016) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0042-107410 · Cited by 3
Zhang, Y., Lu, L., Hu, Z., Dai, Y., Ahmad, N. J. B., Ng, J. L., Chan, C., Hossain, M. Z., Loh, A. H. L., Ward, J. M., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.904 · Cited by 3
Moustafa, B. H., El-Kersh, M. M. E.-D., Shalaby, S. A., Salam, N. A., Moselhy, S., Soliman, G. T., Selim, A., Amer, Y. S., & Baky, A. A. (2023) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-022-00119-w · Cited by 3
Moustafa, B. H., Moselhy, S., Rabie, M. M., Hammad, A. M., Youssef, D., Shouman, M. G., Makar, S. H., Badr, A., Mansour, S. A., Ebrahim, D., et al. (2023) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-022-00118-x · Cited by 3
Self-citationFocal Segmental Glomerulosclerosis
D’Agati, V. D., Jennette, J. C., Alton B. “Brad” Farris, III, Herlitz, L. C., Kambham, N., & Troxell, M. L. (2005) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/1881041964-06 · Cited by 3
Liên, N. T. K., Đếm, P. V., Hương, N. T., Điền, T. M., Thuỷ, T. T. T., Tung, N. V., Hoàng, N. H., & Hương, N. T. Q. (2019) · Medicina · doi:10.3390/medicina55040102 · Cited by 3
“The oligonucleotide primers were synthesized and purchased from IDT (Integrated DNA Technologies, Inc., Coralville, IA, USA) [11,28,32,35] for amplifying the NPHS1, NPHS2, PLCE1 and WT1 genes, respectively.”
Focal Segmental Glomerulosclerosis
Mason, P. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-76419-7_21 · Cited by 3
Molecular genetic analysis of Steroid Resistant Nephrotic Syndrome: Detection of a novel mutationPreprint
Serajpour, N., Karimi, B., Hooman, N., Hosseini, R., Khosravi, P., Rasouly, H. M., & Shojaei, A. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/305987 · Cited by 3
Platt, C. J., Bierżyńska, A., Ding, W., Saleem, S. A., Koziell, A. B., & Saleem, M. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-68837-2 · Cited by 2
“The advancement of genomic sequencing technologies has identified the next largest subset of SRNS as being caused by single gene (monogenic) disorders, which account for up to 30% of cases 12–14 .”
BackgroundIndications for genetic testing in adults with focal segmental glomerulosclerosis
Teran, M. P., Shabaka, A., Furlano, M. M., Tato, A., Carrillo, I. G., Gutiérrez, E., Torrá, R., & Juarez, G. M. F. (2025) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2025.02.001 · Cited by 4
Mascarenhas‐Melo, F., Martins, B., Monteiro, I., Lohani, A., & Krambeck, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188760 · Cited by 2
“Secondary FSGS, resulting from identifiable causes such as adaptive responses to reduced nephron mass, viral infections, drugs, or genetic mutations, is generally more common than primary FSGS [36].”
Miyasako, K., Maeoka, Y., Adachi, Y., Tamura, R., Ishiuchi, N., Nagano, C., Nozu, K., & Masaki, T. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04441-4 · Cited by 2
“Additionally, 25–30% of SRNS in patients under 25 years old are associated with single-gene mutations [6, 13], suggesting that familial FSGS is more prevalent than previously recognized.”
Gene modification: Exploring the potential in treating kidney diseases
Ekperikpe, U. S., Zhao, S., & Daehn, I. S. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108104 · Cited by 5
NPHS2 Revisited Through 208 Cases and Podocin Complex Modeling
Mertens, N. D., Nicolas, C., Bolsius, L., Shril, S., Majmundar, A. J., Huber, T. B., Hildebrandt, F., & Buerger, F. (2026) · Kidney International Reports · doi:10.1016/j.ekir.2026.106366 · Cited by 3
“4,6,39 All variants were confirmed by Sanger sequencing and segregation when parental DNA was available.”
Self-citationOatley, Z., Jaber, D., Rayarakula, N., Guirguis, T., Khawaja, L. M., Bhindwallam, S., Aguirre, M., Restrepo, J. M., & Raina, R. (2026) · Cell Transplantation · doi:10.1177/09636897261417049 · Cited by 3
NPHS2 Mutations in Familial Steroid Resistant Nephrotic Syndrome in Gaza
Sharif, F. A. (2017) · International Journal of Nephrology and Urological Disorders · doi:10.25141/2577-0152-2017-1.0027 · Cited by 2
“This mutation was reported before in a homozygous form in two patients of Arabic origin [15].”
BackgroundDavis, J., Tjipto, A., Hegerty, K., & Mallett, A. J. (2019) · F1000Research · doi:10.12688/f1000research.19997.2 · Cited by 2
Dawman, L., Kaur, A., Nada, R., Chakraborty, S., Handa, S., Sharawat, I. K., & Tiewsoh, K. (2020) · Journal of Pediatric Genetics · doi:10.1055/s-0040-1718725 · Cited by 2
Clinical Genetic Testing in Children with Kidney Disease
Kang, E., & Lee, B. H. (2021) · Journal of the Korean Society of Pediatric Nephrology · doi:10.3339/jkspn.2021.25.1.14 · Cited by 2
Jalanko, H., & Kääriäinen, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-812534-2.00004-7 · Cited by 2
A Multisystem Mitochondrial Disease Caused by a Novel MT-TL1 mtDNA Variant: A Case Report
Giannese, D., Montano, V., Lopriore, P., Nesti, C., LoGerfo, A., Caligo, M. A., Canto, F. D., Pasquinelli, G., Bonadio, A. G., Moriconi, D., et al. (2022) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-221526 · Cited by 2
“ment decreased proteinuria in primary coenzyme Q10 deficiency [14], while cyclosporine therapy showed some efficacy on nephrotic syndrome in COQ6 mutated patients [15].”
Ocular manifestations of the genetic renal tubulopathies
Yang, G., Mack, H. G., Harraka, P. A., Colville, D. J., & Savige, J. (2023) · Ophthalmic Genetics · doi:10.1080/13816810.2023.2253901 · Cited by 3
“(5,6) or for Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) (10”
BackgroundIn vivo characterization of a podocyte-expressed short podocin isoform
Butt, L., Unnersjö‐Jess, D., Reilly, D., Hahnfeldt, R., Rinschen, M. M., Bożek, K., Schermer, B., Benzing, T. R., & Höhne, M. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03420-x · Cited by 2
“NPHS2 , the gene encoding podocin, is ranked among the most frequently mutated genes in patients with genetic steroid-resistant nephrotic syndrome (SRNS) [1] or focal and segmental glomerulosclerosis (FSGS) [2, 3].”
BackgroundPediatric contributions and lessons learned from the NEPTUNE cohort study
Modi, Z. J., Zhai, Y., Yee, J., Desmond, H. E., Hao, W., Sampson, M. G., Sethna, C. B., Wang, C.-S., Gipson, D. S., Trachtman, H., et al. (2024) · Pediatric Nephrology · doi:10.1007/s00467-023-06256-7 · Cited by 2
“…is more impactful in adults Obesity is associated with lower risk of disease remission Passive smoking associated with increased proteinuria [21–25, 29, 30] Genetics Only 5.6% of children with nephrotic syndrome have monogenic disease High-risk APOL1 genotypes associated with more…”
InfluentialQuantitative phenotyping of Nphs1 knockout mice as a prerequisite for gene replacement studies
Buerger, F., Merz, L. M., Saida, K., Yu, S., Salmanullah, D., Lemberg, K., Mertens, N. D., Mansour, B., Kolvenbach, C. M., Yousef, K., et al. (2024) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00412.2023 · Cited by 2
Self-citationMarquez, J., O’Sullivan, L., Squire, A. E., Ryan, G. L., Debiec, K. E., Oelschlager, A. A., & Adam, M. P. (2025) · Frontiers in Nephrology · doi:10.3389/fneph.2025.1542475 · Cited by 2
Suresh, P. K., Venkatachalapathy, Y., Doss, C. G. P., Geminiganesan, S., Ekambaram, S., & MohanaPriya, C. D. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108584 · Cited by 3
Coenzyme Q Biosynthesis Disorders
Brea‐Calvo, G., Alcázar‐Fabra, M., Trevisson, E., & Navas, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-70147-5_6 · Cited by 2
4th Rare Disease South Eastern Europe (See) Meeting Skopje, Macedonia (November 14th, 2015)
Gucev, Z. S., Tasic, V. B., & Polenakovic, M. H. (2015) · PRILOZI · doi:10.1515/prilozi-2015-0091 · Cited by 2
“The health authorities should understand the urgent need for clinical utility of the modern genetic techniques in our country! Velibor Tasic, Skopje, Macedonia spoke about the steroid-resistant nephrotic syndrome (SRNS) [3, 4, 5].”
BackgroundInfluentialGillies, C. E., Otto, E. A., Vega-Warner, V., Robertson, C. C., Sanna‐Cherchi, S., Gharavi, A. G., Crawford, B. D., Bhimma, R., Winkler, C. A., Nephrotic Syndrome Study Network (NEPTUNE), et al. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1108-4 · Cited by 2
“Following multiplexed microfluidic PCR amplification and subsequent sequencing, a common approach to data analysis involves using commercial software for sequence alignment and variant calling [2, 4].”
MethodSelf-citationVince, N., Poschmann, J., Josien, R., Anegón, I., Limou, S., & Gourraud, P. (2018) · Transplantation · doi:10.1097/tp.0000000000002517 · Cited by 2
“47-50 She emphasized how the use of targeted NGS panel can help provide a precise diagnosis and genetic counseling to guide treatment and improve prognosis, notably in the assessment of recurrence risk after kidney transplantation.”
Molecular genetics of inherited kidney disease in Saudi Arabia
Al‐Hamed, M. H., Imtiaz, F., & Kari, J. A. (2018) · Journal of Biochemical and Clinical Genetics · doi:10.24911/jbcgenetics/183-1529935373 · Cited by 2
Self-citationChromosome HeatMap in CDK Patients as Defined by Multiregional Sequencing on Illumina MiSeq Platform
Fazaludeen, M. F., Warille, A. A., Alaraj, M., & Nuglozeh, E. (2020) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2020.2.6.525 · Cited by 2
Evaluation of Genetic Kidney Disease in Living Donor Candidates
Thomas, C. P., & Divers, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-53618-3_8 · Cited by 2
How Genetics Can Improve Clinical Practice in Chronic Kidney Disease: From Bench to Bedside
Piras, D., Lepori, N., Cabiddu, G., & Pani, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020193 · Cited by 2
“Remarkably, some variants were typically associated with early onset nephrotic syndrome (NS), while others with late onset NS [46].”
BackgroundAtypical severe early-onset nephrotic syndrome: Answers
Berthaud, R., Heidet, L., Oualha, M., Brat, R., Talmud, D., Garaix, F., Rabant, M., Frémeaux‐Bacchi, V., Antignac, C., Boyer, O., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05537-x · Cited by 2
“Other genetic causes include mainly NPHS2, WT1, PLCE1, or LAMB2 variants [7].”
BackgroundThomasová, D., Zelinová, M., Libik, M., Géryk, J., Votýpka, P., Bloudíčková, S. R., Krejčí, K., Reiterová, J., Jančová, E., Machová, J., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1320054 · Cited by 2
Nephrotic syndrome and mitochondrial disorders: answers
Bernardor, J., Faudeux, C., Chaussenot, A., Antignac, C., Goldenberg, A., Gübler, M.-C., Wagner, N., & Bérard, E. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-04217-7 · Cited by 2
Familial focal segmental glomerulosclerosis with PLCE 1 mutation in siblings
Shimizu, M., Irabu, H., Kaneda, H., Ohta, K., & Nozu, K. (2019) · Pediatrics International · doi:10.1111/ped.13870 · Cited by 2
Schaefer, F. S. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14241119 · Cited by 2
Genetics of Focal Segmental Glomerulosclerosis in African American Children
Levy, R. V., Kopp, J. B., & Franceschini, N. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.02.001 · Cited by 2
Steroidresistant nephrotic syndrome in a child associated with a mutation in the INF2 gene
Zhuravleva, N. S., Frayfeld, Т. A., Vorobyeva, O. A., Telina, A. S., & Mineeva, N. Y. (2022) · Ural Medical Journal · doi:10.52420/2071-5943-2022-21-3-107-113 · Cited by 1
“СРНС является генетически и фенотипически гетерогенным заболеванием, идентифицировано более 60 моногенных причин его развития [5, 7, 10, 12, 13, 14].”
Le syndrome néphrotique de l’enfant : quoi de neuf en 2023 ?
Boyer, O., & Dorval, G. (2023) · Perfectionnement en Pédiatrie · doi:10.1016/j.perped.2023.04.008 · Cited by 1
The View of Pediatric Nephrotic Syndrome as a Podocytopathy
de Castro, P. A. S. V., Ide, T. F., Torres, F. C., & Silva, A. C. S. E. (2023) · Kidney and Dialysis · doi:10.3390/kidneydial3040030 · Cited by 6
“If NS begins after 1 year of age, only 25% of cases are associated with genetic mutations [60].”
BackgroundSwollen Feet: Considering the Paradoxical Roles of Interleukins in Nephrotic Syndrome
Kovalik, M. E., Dacanay, M. A., Crowley, S. D., & Hall, G. (2024) · Biomedicines · doi:10.3390/biomedicines12040738 · Cited by 2
Patient-specific hiPSC-Podocytes as an in vitro model of genetic FSGS
Rose, V., Fink, D., Krüger, R., Kraus, A., Schödel, J., Schiffer, M., & Müller‐Deile, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-25650-9 · Cited by 1
Immune mechanisms and immunomodulatory therapies in steroid-resistant nephrotic syndrome
Deng, J., Zhu, L., & Zhu, X. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2556486 · Cited by 1
Azouaou, L., Adnane, M., Benabadji, M., Oukrif, L., & Bensnouci, A. (2026) · Pediatric Nephrology · doi:10.1007/s00467-026-07162-4 · Cited by 1
Zhu, Y., Wang, Y., Haider, C. G., Cao, C., Ouzaouit, A., Fu, Y., Huang, H., Jiang, T., Zhou, Y., Zhang, X., et al. (2026) · iScience · doi:10.1016/j.isci.2026.114973 · Cited by 1
Nephrotic Syndrome: Current Management
Vasudevan, A., & Hamsa, V. (2026) · The Indian Journal of Pediatrics · doi:10.1007/s12098-026-06132-w · Cited by 1
Sarrasin, H., Sidler, D., Bartholdi, D., Zweier, C., Girardi, V., Vogt, B., & Bocchi, F. (2026) · Journal of Nephrology · doi:10.1093/joneph/aajaf054 · Cited by 1
Liu, Z.-Y., & Zhou, X.-J. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102226 · Cited by 1
“4,6,9,48,54 Clarification of etiology has profound clinical implications: it enables precision in prognostic counseling, informs treatment decisions, including avoidance of ineffective therapies, supports reproductive planning, and facilitates cascade testing of at-risk relatives.”
Thammathiwat, T., Kongtal, N., Chompuk, L., Khutanthong, S., Suwatronnakorn, B., & Kanjanabuch, T. (2026) · Glomerular Diseases · doi:10.1159/000552476 · Cited by 1
“Steroid-resistant nephrotic syndrome (SRNS) in children and young adults represents a clinically heterogeneous entity encompassing both immune-mediated disease and monogenic podocytopathies [1].”
Clinical impact of genetic testing in inherited kidney diseases
Merz, L. M., Stopp, S., Krey, I., Baalmann, F., Marczak, E., Liebmann, N., Hempel, O., Krüger, B. M., Engesser, M., Teichmann, A., et al. (2026) · Clinical Kidney Journal · doi:10.1093/ckj/sfag160 · Cited by 1
“The introduction of panel sequencing significantly improved diagnostic yields in IKDs [ 28 , 29 ] and ES has since expanded the number of known monogenic disease genes to over 600 [ 30 ].”
Self-citationIdiopathic pediatric chronic kidney disease: can genomic technology crack the case?
Pollak, M. R. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81509 · Cited by 1
“Therapeutic decisions and recommendation for kidney transplantation may be altered by the knowledge gained from such testing (6).”
BackgroundActualizing the Benefits of Genomic Discovery in Pediatric Nephrology
Sampson, M. G. (2015) · Journal of Pediatric Genetics · doi:10.1055/s-0035-1557113 · Cited by 1
A Familial Infantile Renal Failure
Sethi, S. K., Wadhwani, N., Jha, P. K., Duggal, R., Vega-Warner, V., Raina, R., Bansal, S. B., Kher, V., Sampson, M. G., & Otto, E. A. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.08.018 · Cited by 1
“Mutations in PLCE1, WT1, and LAMB2 genes can cause isolated diffuse mesangial sclerosis, with PLCE1 being the most common cause.(3,4) It is proposed that renal histopathologic patterns corroborate with the kidney developmental stages at which PLCE1 activity is required.”
BackgroundSelf-citationFocal segmental glomerulosclerosis: challenges in definitions, pathogenesis and management
Feehally, J. (2017) · African Journal of Nephrology · doi:10.21804/20-1-2546 · Cited by 2
Metadata
- Authors
- Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., Somers, M. J., Tan, W., Shril, S., Fessi, I., Lifton, R. P., Bockenhauer, D., El-Desoky, S., Kari, J. A., Zenker, M., Kemper, M. J., Mueller, D., Fathy, H. M., Soliman, N. A., & Hildebrandt, F.
- Affiliations
- Boston Children's Hospital (US)
- University of Michigan (US)
- Howard Hughes Medical Institute (US)
- King Abdul Aziz University Hospital (SA)
- Otto-von-Guericke-Universität Magdeburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Stiftung Charité (DE)
- Alexandria University (EG)
- Cairo University (EG)
- Corresponding author
- Sadowski, Carolin E.
- Lovric, Svjetlana
- Ashraf, Shazia
- Pabst, Werner L.
- Gee, Heon Yung
- Kohl, Stefan
- Engelmann, Susanne
- Fang, Humphrey
- Halbritter, Jan
- Somers, Michael J.
- Tan, Weizhen
- Shril, Shirlee
- Fessi, Inès
- Kemper, Markus J.
- Hildebrandt, Friedhelm
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-06
- Volume
- 26
- Issue
- 6
- Pages
- 1279-1289
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4446877
- OpenAlex
- W2163605874
- Cited by
- 651
- References
- 41
- Citations by year
- 2026: 45 · 2025: 40 · 2024: 45 · 2023: 63 · 2022: 69 · 2021: 61 · 2020: 55 · 2019: 55 · 2018: 64 · 2017: 62 · 2016: 50 · 2015: 40
- FWCI
- 40.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Nephcure Foundation
- Kidney Research UK (RP45/2008)
- National Institutes of Health
- Manton Center for Orphan Disease Research, Boston Children's Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases (RC4-DK076683, P30DK079310, R01DK076683)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- steroid-resistant nephrotic syndrome, NPHS2, WT1, PLCE1, coenzyme Q10 biosynthesis, age of onset, genotype-phenotype correlation, molecular genetic diagnosis, pediatric kidney disease, end-stage renal disease
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Female, Genotype, Heterozygote, Humans, Infant, Male, Membrane Proteins, Middle Aged, Mutation, Nephrotic Syndrome, Pedigree, Phenotype, Retrospective Studies, Cohort Studies, Incidence, Genes, Wilms Tumor, Age of Onset, Risk Assessment, Genetic Predisposition to Disease, Intracellular Signaling Peptides and Proteins, Young Adult, Genetic Association Studies, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.